Sucrosomial Iron

Phase 3Small molecule

CCardiochirurgia E.H.

Sucrosomial Iron is one of 46 small molecule programs targeting Prospective. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ProspectiveNot yet recruiting

RandomizedCompleted

DonorActive, not recruiting

ProspectivePhase 3

Not yet recruiting

RandomizedPreclinical

Completed

DonorPreclinical

Active, not recruiting

Competition

Competitive Landscape

35 competitors in Randomized

#DrugCompanyPhaseTrials

Rayos

RRoxane Laboratories

Phase 3

3 2

Yondelis

AApotex Inc.

Phase 3

1 3

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3

1 4

Methylthioninium Chloride

PProvepharm SAS

Phase 3

1 5

Rituxan

Roche

Phase 2

2 6

Zytiga

Johnson & Johnson

Phase 2

2 7

Erleada

Johnson & Johnson

Phase 2

1 8

Clomid

Ferring

Phase 2

1 9

Casodex

IIstituto Clinico Humanitas

Phase 2

1 10

Nublexa

BBeijing InnoCare Pharma Tech Co., Ltd.

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Heart Failure2 trials

Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency

Unknown status·UUniversity of Padova·Phase 4·NCT05702970·258 enrolled

Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)

Completed·IInstitut de Recerca Biomèdica de Lleida·Phase 3·NCT03833336·72 enrolled

Randomized1 trial

CardioSideral Heart Surgery: Randomized Study on Sucrosomial Iron Supplementation Before Heart Surgery

Completed·CCardiochirurgia E.H.·N/A·NCT03560687·1,023 enrolled

Prospective1 trial

DOSE FINDING PROSPECTIVE ANALYSIS AFTER HEART SURGERY for Sucrosomial Iron

Not yet recruiting·CCardiochirurgia E.H.·Phase 4·NCT07038330·150 enrolled

Donor1 trial

Sucrosomial Iron and Iron Sulphate to Blood Donors

Active, not recruiting·UUppsala University Hospital·N/A·NCT05678647·120 enrolled

Inflammatory Bowel Disease1 trial

Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial

Unknown status·FFondazione IRCCS Policlinico San Matteo di Pavia·Phase 3·NCT04587141·300 enrolled

1 more indication

Iron deficiency anemia1 trial

Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis

Unknown status·—·Phase 3·NCT05225545·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Sucrosomial Iron. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Sucrosomial Iron compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Sucrosomial Iron. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Cardiochirurgia E.H. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: CCardiochirurgia E.H.

Sucrosomial Iron

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Heart Failure2 trials

Randomized1 trial

Prospective1 trial

Donor1 trial

Inflammatory Bowel Disease1 trial

Iron deficiency anemia1 trial

References

Drug Info

Quick Facts

Related News